REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
8.82
-0.24 (-2.65%)
At close: Aug 15, 2025, 3:59 PM
8.91
0.96%
After-hours: Aug 15, 2025, 06:29 PM EDT

REGENXBIO Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-70.87M 6.08M -51.19M -59.6M -52.99M -63.33M -62.89M -61.87M -72.06M -66.68M -59.94M -75.48M -68.18M -76.72M 294.02M -58.41M -57.64M -50.14M
Depreciation & Amortization
3.9M 3.96M 4.02M 3.96M 4.05M 4.18M 4.33M 4.37M 4.43M 4.18M 4.13M 3.55M 2.64M 2.59M 2.61M 2.83M 2.2M 1.93M
Stock-Based Compensation
8.65M 8.54M 9.54M 9.88M 9.44M 9.6M 8.34M 10.22M 10.5M 11.21M 9.41M 10.24M 10.34M 10.8M 9.16M 9.73M 9.99M 9.92M
Other Working Capital
n/a 18.49M 486K 9.78M 17.77M -25.8M 4.63M -6K -779K -36M 50K -2.37M 5.62M -16.4M 28.91M 480K 12.12M 414.68M
Other Non-Cash Items
8.97M -1.36M -5.66M -6.99M 37.39M 2.57M 12.65M 831K -705K -14K 228K 1.25M 1.02M 1.38M -21.66M 8.06M 6.1M 6.52M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -12.42M -2.34M 380K n/a n/a n/a n/a n/a n/a n/a 1.58M 1.85M
Change in Working Capital
n/a 16.41M 11.66M 12.19M -4.04M -8.16M 9.22M -623K 10.13M -29.61M 6.8M 9.99M -8.86M 6.04M 42.11M 1.43M 7.89M -11.21M
Operating Cash Flow
-49.34M 33.63M -31.62M -40.55M -45.5M -55.45M -40.76M -49.41M -47.32M -80.92M -39.37M -50.46M -61.75M -55.91M 326.24M -36.36M -29.87M -41.13M
Capital Expenditures
-391K -1.02M -1.08M -326K -474K -557K -1.13M -1.44M -2.58M -4.82M -5.47M -5.05M -9.24M -10.97M -14.61M -18.7M -19.84M -31.02M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -35.1M -40.1M -57.8M n/a n/a -58.09M n/a n/a -4.99M n/a n/a n/a
Purchase of Investments
-211.14M -19.16M -16.22M -36.2M -82.53M -55.19M -18.64M -18.13M -49.8M n/a -11.96M -14.55M -28.87M -129.49M -235.47M -20.68M -8.36M -233.63M
Sales Maturities Of Investments
71.1M 64.92M 57.58M 86.78M 82.73M 68.93M 53.74M 58.23M 107.59M 67.91M 44.13M 72.64M 37.03M 49.86M 33.73M 55.48M 36.01M 50.47M
Other Investing Acitivies
n/a n/a n/a n/a 206K 13.74M 35.1M 40.1M 57.8M 67.91M n/a 58.09M 8.16M -79.62M 4.99M 34.8M 27.64M -183.16M
Investing Cash Flow
-140.44M 44.74M 40.27M 50.26M -268K 13.18M 33.97M 38.66M 55.22M 63.09M 26.7M 53.04M -1.08M -90.59M -216.36M 16.1M 7.8M -214.18M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a 307K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
139.23M -6.1M -7.74M -11.1M -9.45M -11.29M -11.96M -4.8M -9.16M -9.62M -8.92M -6.54M -7.67M -7.46M 7.64M -3.42M -6.14M -5.78M
Financial Cash Flow
139.23M -5.79M -7.74M -10.86M -9.45M 120.72M -11.96M -4.8M -9.16M -9.04M -8.92M -5.42M -7.67M -6.83M -7.62M -2.28M -6.14M 211.29M
Net Cash Flow
-50.55M 72.58M 909K 882K -55.21M 78.45M -18.52M -15.55M -1.27M -26.86M -21.59M -2.83M -70.5M -153.34M 117.52M -28.68M -34.41M -46.94M
Free Cash Flow
-49.73M 32.6M -32.7M -40.88M -45.97M -56.01M -41.89M -50.85M -49.9M -85.74M -44.84M -55.51M -70.99M -66.88M 311.62M -55.06M -49.71M -72.15M